Drug Trial Radar · NCT02628665
Clinical Study of Time Optimizing of Endoscopic Photodynamic Therapy on Esophageal and/or Gastric Cardiac Cancer
Last checked: Nov 19, 2026Latest source record: Dec 11, 2015 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
40
Planned (sponsor's estimate)
Start
Oct 2015
Primary completion
Oct 2017
Study completion Dec 2019
Sponsor
- Lead sponsor
- The First Affiliated Hospital of Henan University of Science and TechnologyAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Dec 11, 2015
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The therapy of photofrin PDT was effective in improving life quality of patients with advanced esophageal and/or gastric cardiac cancer and the time optimizing for employing laser irradiation was of great importance.The purpose of this study is to evaluate the clinical efficacy and adverse effects of Photodynamic Therapy (PDT) on esophageal and/or gastric cardiac cancer during different time after inject photofrin.
Conditions
- Stage I Esophageal Adenocarcinoma
- Stage II Esophageal Adenocarcinoma
- Stage III Esophageal Adenocarcinoma
- Stage I Esophageal Squamous Cell Carcinoma
- Stage II Esophageal Squamous Cell Carcinoma
- Stage III Esophageal Squamous Cell Carcinoma
Interventions
photosensitizer(photofrin)Drug
photosensitizer(photofrin): 2mg/kg
630 nm laser irradiation (DIOMED)Device
630 nm laser irradiation (DIOMED): The diseased tissue with laser irradiation in 1200 seconds.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Partial remission rateTime frame: 3 months
Locations
1 site in 1 country. Site status is shown where the registry gives one.
The First Affiliated Hospital of Henan University of Science and Technology
Luoyang, Henan, China · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.